A randomized, double-blind, placebo-controlled, phase III study in patients (Pts) with metastatic adenocarcinoma of the colon or rectum receiving first-line chemotherapy with oxaliplatin/5-fluorouracil/leucovorin and PTK787/ZK 222 584 or placebo (CONFIRM-1). - Hecht,J.R.; Trarbach,T.; Jaeger,E. (Proc ASCO, 2005)